- Home
- SNDX vs SKE Comparison
SNDX vs SKE Comparison
Compare SNDX & SKE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNDX
- SKE
- Stock Information
- Founded
- SNDX 2005
- SKE 1979
- Country
- SNDX United States
- SKE Canada
- Employees
- SNDX N/A
- SKE N/A
- Industry
- SNDX Biotechnology: Pharmaceutical Preparations
- SKE Precious Metals
- Sector
- SNDX Health Care
- SKE Basic Materials
- Exchange
- SNDX Nasdaq
- SKE Nasdaq
- Market Cap
- SNDX 1.1B
- SKE 997.4M
- IPO Year
- SNDX 2016
- SKE N/A
- Fundamental
- Price
- SNDX $13.08
- SKE $9.43
- Analyst Decision
- SNDX Strong Buy
- SKE
- Analyst Count
- SNDX 10
- SKE 0
- Target Price
- SNDX $36.20
- SKE N/A
- AVG Volume (30 Days)
- SNDX 2.6M
- SKE 266.3K
- Earning Date
- SNDX 02-25-2025
- SKE 11-14-2024
- Dividend Yield
- SNDX N/A
- SKE N/A
- EPS Growth
- SNDX N/A
- SKE N/A
- EPS
- SNDX N/A
- SKE N/A
- Revenue
- SNDX $16,000,000.00
- SKE N/A
- Revenue This Year
- SNDX N/A
- SKE N/A
- Revenue Next Year
- SNDX $14.15
- SKE $50.00
- P/E Ratio
- SNDX N/A
- SKE N/A
- Revenue Growth
- SNDX N/A
- SKE N/A
- 52 Week Low
- SNDX $12.06
- SKE $3.29
- 52 Week High
- SNDX $25.34
- SKE $10.33
- Technical
- Relative Strength Index (RSI)
- SNDX 41.29
- SKE 53.14
- Support Level
- SNDX $12.40
- SKE $8.91
- Resistance Level
- SNDX $13.16
- SKE $10.23
- Average True Range (ATR)
- SNDX 0.65
- SKE 0.45
- MACD
- SNDX 0.10
- SKE 0.01
- Stochastic Oscillator
- SNDX 39.38
- SKE 51.22
About SNDX Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. The company's product candidates are entinostat which has direct effects on both cancer cells and immune regulatory cells, SNDX-6352 and SNDX-6352, an anti-CSF-1R monoclonal antibody, to enhance the body's immune response on tumors that have shown sensitivity to immunotherapy. Business activity of the group is primarily functioned through the region of United States.
About SKE Skeena Resources Limited
Skeena Resources Ltd is a Canadian mining exploration company focused on developing prospective precious and base metal properties in the Golden Triangle of northwest British Columbia, Canada. The company's primary activity is the exploration and development of the past-producing Eskay Creek mine acquired from Barrick.